Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin

TUESDAY, Sept. 19, 2023 -- For female survivors of childhood cancer, the risk for subsequent breast cancer (SBC) is more than twofold higher for those who receive a cumulative dose of 200 mg/m ² or more of doxorubicin compared with those who never...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news